3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Blood Cancer -

Pet pig Nemo’s lymphoma treatment makes research history

Cancer • • Blood CancerJul 24, 13

When George Goldner went to feed his six pet pigs earlier this year, his 730-pound (331-kg) companion Nemo was acting strangely. Nemo had suddenly stopped eating and laid in the mud.

So Goldner loaded Nemo into a trailer and drove more than two hours to Cornell University Hospital for Animals (CUHA) in Ithaca, New York. There he learned his four-year-old Hampshire pig had what doctors believed was the blood cancer B-cell lymphoma.

The hospital’s researchers told Goldner they had never seen a pig treated for cancer. But that did not deter Goldner, a self-described animal lover, who asked doctors to devise a way to treat his pig based on their knowledge of cancer in dogs and humans and not worry about costs.

Now, four months after Goldner first rushed to the hospital, Nemo has made history as the first known pig to undergo lymphoma treatment - and successfully - leaving researchers with hope for advancements in treating cancer in large animals.

“Before when large animals were diagnosed with cancer, it was pretty much impossible to treat them,” said Emily Barrell, a resident who picked all of Nemo’s chemotherapy drugs and delivered them. “Now we have a model to base it on.”

Because pigs have necks bigger than many humans, their veins are difficult to access, Barrell said, making it impossible to deliver many of the aggressive drugs needed for chemotherapy.

Doctors at CUHA consulted with researchers in other fields before implanting a vascular access port, which is a small metal port with a silicone cover, directly under Nemo’s skin behind his ear.

The port contained a catheter that ran through a jugular vein in his neck, allowing Nemo to receive the sort of cancer treatment administered to dogs and humans.

Nemo is now believed to be in remission, Barrell said, and will return home in September if everything goes according to plan.

Goldner and doctors at CUHA declined to specify how much Nemo’s treatment cost. The cost of chemotherapy for an average-sized golden retriever is $4,000-$5,000 from start to finish, Barrell said, and Nemo is seven or eight times the size of that.

“There were two choices: One was to let him die and the other was to give it a shot,” Goldner said in an interview. “Now I think (Nemo) is definitely bound to provide some help.”

Though some may criticize the cost of treating such large animals, Barrell said it has become common practice for cat and dog owners to pay for cancer treatment, and it is up to owners to decide how much they are willing to pay.

“This is exactly the type of clinical veterinary research we should be doing to treat disease in other animals,” said Justin Goodman, director of laboratory investigation at animal rights group PETA.

Nemo’s appetite is back and he’s treated like a “big star” at CUHA, Goldner said.

“(Nemo) is a really special story about people being innovative and owners being dedicated,” Barrell said.

###

By Yasmeen Abutaleb



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site